Ancora Advisors’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-58,789
| Closed | -$3.48M | – | 2500 |
|
|
2025
Q4 | $3.48M | Sell |
58,789
-41,251
| -41% | -$2.24M | 0.07% | 220 |
|
|
2025
Q3 | $5.52M | Sell |
100,040
-14,150
| -12% | -$736K | 0.11% | 172 |
|
|
2025
Q2 | $4.92M | Sell |
114,190
-62,420
| -35% | -$2.41M | 0.1% | 181 |
|
|
2025
Q1 | $6.99M | Buy |
176,610
+88,380
| +100% | +$3.91M | 0.16% | 130 |
|
|
2024
Q4 | $3.6M | Buy |
88,230
+78,420
| +799% | +$3.27M | 0.08% | 201 |
|
|
2024
Q3 | $383K | Buy |
+9,810
| New | +$391K | 0.01% | 559 |
|
|
2023
Q4 | – | Sell |
-880
| Closed | -$41.9K | – | 1807 |
|
|
2023
Q3 | $41.9K | Hold |
880
| – | – | ﹤0.01% | 962 |
|
|
2023
Q2 | $51.2K | Sell |
880
-50,054
| -98% | -$3M | ﹤0.01% | 904 |
|
|
2023
Q1 | $3.64M | Sell |
50,934
-85,220
| -63% | -$6.76M | 0.1% | 167 |
|
|
2022
Q4 | $9.59M | Sell |
136,154
-2,000
| -1% | -$141K | 0.28% | 67 |
|
|
2022
Q3 | $8.38M | Sell |
138,154
-8,820
| -6% | -$592K | 0.26% | 78 |
|
|
2022
Q2 | $9.28M | Buy |
146,974
+32,180
| +28% | +$2.1M | 0.26% | 85 |
|
|
2022
Q1 | $7.36M | Buy |
114,794
+103,540
| +920% | +$6.93M | 0.18% | 117 |
|
|
2021
Q4 | $807K | Sell |
11,254
-1,026
| -8% | -$78K | 0.02% | 432 |
|
|
2021
Q3 | $876K | Sell |
12,280
-100
| -0.8% | -$7.89K | 0.02% | 408 |
|
|
2021
Q2 | $1.01M | Sell |
12,380
-6,760
| -35% | -$544K | 0.03% | 396 |
|
|
2021
Q1 | $1.45M | Sell |
19,140
-6,070
| -24% | -$442K | 0.04% | 313 |
|
|
2020
Q4 | $1.91M | Buy |
25,210
+5,500
| +28% | +$358K | 0.06% | 262 |
|
|
2020
Q3 | $974K | Buy |
19,710
+11,840
| +150% | +$668K | 0.04% | 323 |
|
|
2020
Q2 | $414K | Buy |
7,870
+5,360
| +214% | +$254K | 0.02% | 462 |
|
|
2020
Q1 | $88K | Buy |
+2,510
| New | +$147K | ﹤0.01% | 800 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | – | – | 995 |
|
|
2018
Q3 | $0 | Buy |
+4
| New | +$386 | ﹤0.01% | 1348 |
|
|
2018
Q1 | – | Sell |
-47,824
| Closed | -$3.37M | – | 694 |
|
|
2017
Q4 | $3.37M | Buy |
47,824
+9,660
| +25% | +$697K | 0.18% | 163 |
|
|
2017
Q3 | $2.38M | Buy |
38,164
+4,523
| +13% | +$268K | 0.14% | 192 |
|
|
2017
Q2 | $1.93M | Buy |
33,641
+1,898
| +6% | +$112K | 0.13% | 202 |
|
|
2017
Q1 | $1.93M | Buy |
31,743
+2,166
| +7% | +$123K | 0.13% | 201 |
|
|
2016
Q4 | $1.62M | Buy |
29,577
+3,689
| +14% | +$177K | 0.12% | 214 |
|
|
2016
Q3 | $1.19M | Buy |
25,888
+20,022
| +341% | +$845K | 0.12% | 201 |
|
|
2016
Q2 | $200K | Buy |
+5,866
| New | +$183K | 0.02% | 469 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Ancora Advisors's NGVT Position: Q1 2026 in Review
Ancora Advisors sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 58,789 shares — an estimated $3.48M sold.
Ancora Advisors first reported a position in NGVT in Q2 2016 and held it in 29 quarters. The position peaked at $9.59M in Q4 2022. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Ancora Advisors reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
- Ancora Advisors sold 58,789 Ingevity shares in Q1 2026, an estimated $3.48M.
- Ancora Advisors first reported a position in Ingevity in Q2 2016 and held it in 29 quarters.
- Ancora Advisors's Ingevity position peaked at $9.59M in Q4 2022.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.